Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
2,219
-93
-4% -$42.9K 0.01% 668
2026
Q1
$1.11M Sell
2,312
-1,854
-45% -$949K 0.02% 628
2025
Q4
$2.34M Sell
4,166
-109
-3% -$61.9K 0.04% 433
2025
Q3
$2.2M Buy
4,275
+1,148
+37% +$501K 0.04% 420
2025
Q2
$972K Buy
3,127
+803
+35% +$241K 0.02% 621
2025
Q1
$692K Buy
2,324
+1,547
+199% +$520K 0.01% 686
2024
Q4
$258K Buy
777
+282
+57% +$95.6K 0.01% 979
2024
Q3
$200K Sell
495
-351
-41% -$133K 0.01% 1008
2024
Q2
$348K Buy
846
+351
+71% +$139K 0.01% 866
2024
Q1
$200K Sell
495
-322
-39% -$113K 0.01% 1007
2023
Q4
$250K Buy
+817
New +$221K 0.01% 928

Other funds holding MEDP

Ethic Inc's MEDP Position: Q2 2026 in Review

Ethic Inc reduced its Medpace (MEDP) stake by 4% in Q2 2026, selling an estimated $42.9K and leaving 2,219 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #668.

Ethic Inc first reported a position in MEDP in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.34M in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Ethic Inc held 2,219 shares of Medpace worth $1.18M as of Q2 2026.
  • Ethic Inc sold 93 Medpace shares in Q2 2026, an estimated $42.9K.
  • Medpace made up 0.01% of Ethic Inc's portfolio in Q2 2026, its #668 holding.
  • Ethic Inc first reported a position in Medpace in Q4 2023 and has held it in 11 quarters since.
  • Ethic Inc's Medpace position peaked at $2.34M in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.